PMID:
Panminerva Med. 2019 Oct 25. Epub 2019 Oct 25. PMID: 31670494
Abstract Title:
Episodic primary migraine headache: prophylaxis with Pycnogenol® precents attacks and controls oxidative stress.
Abstract:
BACKGROUND: The present registry study investigated effects of the dietary supplement Pycnogenol® on migraine headache attacks and oxidative stress in otherwise healthy subjects with migraine mild-moderate headache (MH) that were considered. To manage MH, these subjects used only a few drugs (anti-emetics, analgesics on demand) and lifestyle changes; only very occasionally they used other, more specific products such as triptans.METHODS: Study GROUPS: one group used only standard management (SM), basically, management on demand. Oral magnesium and riboflavin (vitamin B2) were used with lipoic acid as they are considered useful to improve MH. Another group used the supplement Pycnogenol® (150 mg/day for 8 weeks) in addition to SM. These two groups were compared to a third (non-parallel, observational) group using topiramate (50 mg/day). If needed, subjects were allowed to use rescue medications.RESULTS: 46 subjects were included in the study. 22 used the standard management and 24 were supplemented with Pycnogenol® in association with SM. In addition, 21 subjects were treated with topiramate. Safety with Pycnogenol® was very good. The two main management groups and the third non-parallel group had comparable baseline characteristics. The number of migraine attacks were significantly reduced during the observation period with Pycnogenol® (p
Health Time 